STRATA Skin Sciences, Inc. announced an exclusive agreement with MINO Labs, a private company that represents international pharmaceutical companies to commercialize innovative products in Mexico, for the distribution of TheraClear®X, VTRAC® and XTRAC® in Mexico for three years.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.105 USD | -4.76% |
|
+7.05% | -43.56% |
05-15 | STRATA Skin Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-15 | Transcript : STRATA Skin Sciences, Inc., Q1 2024 Earnings Call, May 15, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.56% | 11.43M | |
+4.71% | 212B | |
+8.66% | 187B | |
+27.03% | 155B | |
+34.01% | 115B | |
+2.17% | 65.5B | |
+14.05% | 52.87B | |
-3.30% | 45.25B | |
-3.36% | 39.7B | |
+6.48% | 37.72B |
- Stock Market
- Equities
- SSKN Stock
- News STRATA Skin Sciences, Inc.
- STRATA Skin Sciences, Inc. Expands into $300 Million Market with Exclusive Distribution Agreement in Mexico